Investment in later stage clinical development is needed to back up recent improvements in the discovery of new antibiotics, and to ensure the use of novel products is managed to maintain their effectiveness  

After decades of research – much of it funded by the public - gene therapy is a reality. Now high costs are blocking patient access. Prices should be constrained

A new Science|Business report gathers the views of clinical specialists, tech experts, patients and policymakers on how to use health registry data to improve patient outcomes

As member states push for a new research partnership on antimicrobial resistance, EU auditors say efforts to date have failed to reduce the threat to human health

The number of knee replacements doubled in 16 years, but did recipients’ lives improve as a result? With health expenditure set to outpace GDP growth, collecting data to answer questions like this is crucial